Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND B2M, P61769, 567, ENSG00000166710 AND Clinical Outcome
4 results:

  • 1. Immune Marker Spatial Distribution and clinical outcome after PD-1 Blockade in Mismatch Repair-deficient, Advanced colorectal Carcinomas.
    Saberzadeh-Ardestani B; Graham RP; McMahon S; Ahanonu E; Shi Q; Williams C; Hubbard A; Zhang W; Muranyi A; Yan D; Jin Z; Shanmugam K; Sinicrope FA
    Clin Cancer Res; 2023 Oct; 29(20):4268-4277. PubMed ID: 37566222
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Favorable long-term clinical outcome of uncovered D-weave stent placement as definitive palliative treatment for malignant colorectal obstruction.
    Tominaga K; Maetani I; Sato K; Shigoka H; Omuta S; Ito S; Saigusa Y
    Dis Colon Rectum; 2012 Sep; 55(9):983-9. PubMed ID: 22874606
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.
    Bokemeyer C; Bondarenko I; Hartmann JT; de Braud F; Schuch G; Zubel A; Celik I; Schlichting M; Koralewski P
    Ann Oncol; 2011 Jul; 22(7):1535-1546. PubMed ID: 21228335
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cost analysis of transanal endoscopic microsurgery for rectal tumours.
    Maslekar S; Pillinger SH; Sharma A; Taylor A; Monson JR
    Colorectal Dis; 2007 Mar; 9(3):229-34. PubMed ID: 17298620
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.